HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Latest Conference Articles

10 Years After HIV PrEP Approval, Uptake Lowest Among Highest Risk Groups

10 Years After HIV PrEP Approval, Uptake Lowest Among Highest Risk Groups

August 9th 2022, 8:30pm

Expanding Medicaid and reducing stigma can bolster equitable HIV PrEP access, Dr. Patrick Sullivan says.

Biktarvy Effective for HIV Patients Coinfected With Hepatitis B

Biktarvy Effective for HIV Patients Coinfected With Hepatitis B

August 1st 2022, 5:00pm

At AIDS 2022, Gilead presented data suggesting Biktarvy was a safe and effective complete HIV treatment regimen, including for those coinfected with hepatitis B.

Fostemsavir Improves Outcomes for Treatment-Resistant HIV Patients

Fostemsavir Improves Outcomes for Treatment-Resistant HIV Patients

July 30th 2022, 3:00pm

After 5 years of treatment, fostemsavir improved immunologic response and virologic outcome in patients with highly resistant HIV infection.

The Patient Impact of CDI, Preventing Reoccurrence

The Patient Impact of CDI, Preventing Reoccurrence

June 1st 2022, 12:00pm

MAD-ID

A clinician discusses the disease burden of reoccurring CDI, but sees a silver lining in the new investigational therapies potentially changing the treatment paradigm for the better.

The Next Big Thing in Stewardship?

The Next Big Thing in Stewardship?

May 29th 2022, 3:58pm

MAD-ID

A clinician is advocating for incorporating diagnostic stewardship practices within antimicrobial stewardship programs, which could someday lead to best practice guidelines on a larger scale.

Rapid Diagnostic Testing’s Impact on Timing to Optimal Therapy

Rapid Diagnostic Testing’s Impact on Timing to Optimal Therapy

May 27th 2022, 1:59pm

MAD-ID

Utilizing a newer technology, investigators wanted to see if a reduction in time led to clinically significant antimicrobial adjustments.

Measuring the Effectiveness of a Novel Antibiotic for Patients with Nontuberculous Mycobacterial Infections

Measuring the Effectiveness of a Novel Antibiotic for Patients with Nontuberculous Mycobacterial Infections

May 27th 2022, 12:16pm

MAD-ID

A multicenter study looked at treating these infections with omadacycline.

Monoclonal Antibody ADG20 Neutralizes COVID-19 Variants

Monoclonal Antibody ADG20 Neutralizes COVID-19 Variants

May 26th 2022, 6:09pm

MAD-ID | Making a Difference in Infectious Diseases

The investigational, fully human IgG1 monoclonal antibody ADG20 prevented and treated infection with COVID-19 variants of concern.

Monitoring Vancomycin Area Under the Curve Dosing

Monitoring Vancomycin Area Under the Curve Dosing

May 26th 2022, 11:52am

MAD-ID

A medical center wanted to review prescribing and documentation practices for their pharmacists.

Investigating RBX2660 for Recurrent C Difficile Infection

Investigating RBX2660 for Recurrent C Difficile Infection

May 24th 2022, 6:00pm

MAD-ID | Making a Difference in Infectious Diseases

RBX2660, an investigational microbiota-based live biotherapeutic for the treatment of C difficile, safely and effectively reduced recurrent C diff for 6 months.